EUVIMEDEUVIMED entdecken
Crossref

Novel Laboratory Markers of Coagulation Disorders in Pregnant Women with Preeclampsia

R.F. Yeromenko, O.M. Lytvynova, H.L. Lytvynenko

Fiziolohichnyĭ zhurnal · 17.06.2026 · 72 (03) · 73-81

DOI: 10.15407/fz72.03.073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fiziolohichnyĭ zhurnal, online erschienen am 17.06.2026. Verfasst von R.F. Yeromenko und 2 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The review addresses current challenges in the early diagnosis of coagulation disorders in pregnant women with preeclampsia, which is one of the most dangerous complications of gestation, characterized by systemic vascular, inflammatory, and hemostatic alterations. The study aimed to analyze modern laboratory markers of coagulation disorders in pregnant women with preeclampsia. A steady annual increase in the number of studies devoted to preeclampsia biomarkers and early risk stratification has been identified. It has been shown that an imbalance of angiogenic factors and the development of endothelial dysfunction represent key pathogenetic mechanisms and precede the clinical manifestation of the disease by several weeks. The most diagnostically and prognostically significant indicators of impaired angiogenesis and markers of coagulation cascade activation have been determined. The role of microRNAs in the regulation of placental function has been highlighted, along with the potential of studying epigenetic markers, cell-free placental DNA, alterations in metabolic pathways, and glycan structures of proteins as sensitive indicators of hypoxia, inflammation, and intercellular dysfunction. In pregnant women with severe preeclampsia, thromboelastography and rotational thromboelastometry have proven particularly informative, allowing comprehensive real-time assessment of the functional state of the hemostatic system. Comprehensive laboratory evaluation incorporating both conventional and novel markers is crucial for optimizing patient management and requires further standardization and scientific refinement.

Zitieren

APA

Yeromenko, R., Lytvynova, O., & Lytvynenko, H. (2026). Novel Laboratory Markers of Coagulation Disorders in Pregnant Women with Preeclampsia. Fiziolohichnyĭ zhurnal, 72(03), 73-81. https://doi.org/10.15407/fz72.03.073

Vancouver

Yeromenko R, Lytvynova O, Lytvynenko H. Novel Laboratory Markers of Coagulation Disorders in Pregnant Women with Preeclampsia. Fiziolohichnyĭ zhurnal. 2026;72(03):73-81. doi:10.15407/fz72.03.073

BibTeX
@article{Yeromenko2026,
  author = {Yeromenko, R.F. and Lytvynova, O.M. and Lytvynenko, H.L.},
  title = {Novel Laboratory Markers of Coagulation Disorders in Pregnant Women with Preeclampsia},
  journal = {Fiziolohichnyĭ zhurnal},
  year = {2026},
  volume = {72},
  number = {03},
  pages = {73--81},
  doi = {10.15407/fz72.03.073}
}
Kostenlos starten →